WMSA
ARIA

Weiss Multi-Strategy Advisers’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-60,000
Closed -$1.1M – 1203
2013
Q3 		$1.1M Buy
+60,000
New +$1.16M 0.02% 395

Other funds holding ARIA

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ARIA Position: Q2 2015 in Review

Weiss Multi-Strategy Advisers sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2015, closing a stake of 60,000 shares — an estimated $494K sold.

Weiss Multi-Strategy Advisers first reported a position in ARIA in Q2 2013 and held it in 7 quarters. The position peaked at $2.1M in Q2 2013. 177 funds tracked by Wall St. Rank hold ARIA as of Q2 2015.

  • Weiss Multi-Strategy Advisers reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 60,000 Ariad Pharmaceuticals Inc shares in Q2 2015, an estimated $494K.
  • Weiss Multi-Strategy Advisers first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 7 quarters.
  • Weiss Multi-Strategy Advisers's Ariad Pharmaceuticals Inc position peaked at $2.1M in Q2 2013.
  • 177 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2015.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2015, filed 14 Aug 2015.